Company Profiles

driven by the PitchBook Platform

Elusys Therapeutics

Description

Developer of antibody therapeutics for the treatment of life-threatening disease and combating other infectious diseases, viruses, toxins and autoimmune diseases. The company is involved in the development of rapid injection, anti-toxin antibody and other products for the prophylaxis and treatment of anthrax disease following a biowarfare attack.

1998

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$5M

Latest Deal Amount

$55.9M

Total Amount Raised

Description

Developer of antibody therapeutics for the treatment of life-threatening disease and combating other infectious diseases, viruses, toxins and autoimmune diseases. The company is involved in the development of rapid injection, anti-toxin antibody and other products for the prophylaxis and treatment of anthrax disease following a biowarfare attack.

Website:

www.elusys.com

Formerly Known As

E-site Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare

Primary Office

25 Riverside Drive Suite one Montville, NJ 07058United States +1 (973) 808-0222
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Elusys Therapeutics's full profile, request a free trial.

Elusys Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Elusys Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Elusys Therapeutics Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ClearBridgeAsset ManagerMinority000 0000000 0000
Crescendo VenturesVenture CapitalMinority000 0000000 0000
Eagle VenturesVenture CapitalMinority000 0000000 0000
Essex WoodlandsGrowth/ExpansionMinority000 0000000 0000
InvescoFund of FundsMinority000 0000000 0000
ClearBridge Asset Manager
Crescendo Ventures Venture Capital
Eagle Ventures Venture Capital
Essex Woodlands Growth/Expansion
Invesco Fund of Funds

Elusys Therapeutics Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Elizabeth Posillico Ph.DPresident, Chief Executive Officer and Board Member
Lawrence GyenesChief Financial Officer
Debra DuffySenior Director, Human Resources & Administration
Jeremy MiddletonVice President, Corporate Development
James PorterVice President, Development and Manufacturing
Elizabeth Posillico Ph.D President, Chief Executive Officer and Board Member
Lawrence Gyenes Chief Financial Officer
Debra Duffy Senior Director, Human Resources & Administration
Jeremy Middleton Vice President, Corporate Development
James Porter Vice President, Development and Manufacturing

Elusys Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
Frank Young Ph.DEssex WoodlandsAdjunct Partner000 0000
Jeffrey Wolf JDSelfBoard Member000 0000
Johnston EvansInvescoGeneral Partner000 0000
Ron EastmanSelfChairman000 0000
Frank Young Ph.D Adjunct Partner Essex Woodlands
Jeffrey Wolf JD Board Member Self
Johnston Evans General Partner Invesco
Ron Eastman Chairman Self
Request full access to PitchBook